JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms

Haematologica - Italy
doi 10.3324/haematol.2014.115113
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms

Leukemia Research
Cancer ResearchOncologyHematology
2016English

JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2010English

Molecular Drug Targets in Myeloproliferative Neoplasms: Mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2008English

MPL W515 L/K Mutations in Myeloproliferative Neoplasms

Egyptian Journal of Medical Human Genetics
Genetics
2019English

Effect of Mutation Order on Myeloproliferative Neoplasms

New England Journal of Medicine
Medicine
2015English

CALR Mutation Analysis Is Not Indicated in Patients With Splanchnic Vein Thrombosis Without Evidence of a Myeloproliferative Neoplasm: A Micro-Review

Annals of Gastroenterology
2016English

Role of Mesenchymal Stromal Cells and Their Extracellular Vesicles microRNAs in JAK2 Myeloproliferative Neoplasms

English

Circulating Endothelial Cells in Patients With Venous Thromboembolism and Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy